A TGF-β autocrine loop is established by the EGFR inhibition in NSCLC with EGFR mutations, facilitating TGF-β-stimulated activation of SMAD pathway, thus playing a crucial role in EMT (18). This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.